BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34340010)

  • 1. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis.
    Zhang H; Wang H; Gao F; Yang J; Xu Y; Fu Y; Cai M; Zhang X; Yang Q; Tong K; Hu Y; Chen H; Ma C; He W; Zhang J
    Neurobiol Aging; 2021 Oct; 106():292-303. PubMed ID: 34340010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition-enhancing effect of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in the 5 × FAD transgenic mouse model of Alzheimer's pathology.
    Dai W; Yao RM; Mi TY; Zhang LM; Wu HL; Cheng JB; Li YF
    J Psychopharmacol; 2022 Oct; 36(10):1176-1187. PubMed ID: 36069168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
    Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
    J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
    Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
    Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease.
    Zhang M; Qian XH; Hu J; Zhang Y; Lin X; Hai W; Shi K; Jiang X; Li Y; Tang HD; Li B
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):455-467. PubMed ID: 37801139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
    Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
    Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
    Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
    J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.
    Biechele G; Blume T; Deussing M; Zott B; Shi Y; Xiang X; Franzmeier N; Kleinberger G; Peters F; Ochs K; Focke C; Sacher C; Wind K; Schmidt C; Lindner S; Gildehaus FJ; Eckenweber F; Beyer L; von Ungern-Sternberg B; Bartenstein P; Baumann K; Dorostkar MM; Rominger A; Cumming P; Willem M; Adelsberger H; Herms J; Brendel M
    Theranostics; 2021; 11(18):8964-8976. PubMed ID: 34522221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between sex, body mass index and the individual microglial response in Alzheimer's disease.
    Biechele G; Rauchmann BS; Janowitz D; Buerger K; Franzmeier N; Weidinger E; Guersel S; Schuster S; Finze A; Harris S; Lindner S; Albert NL; Wetzel C; Rupprecht R; Rominger A; Palleis C; Katzdobler S; Burow L; Kurz C; Zaganjori M; Trappmann LK; Goldhardt O; Grimmer T; Haeckert J; Keeser D; Stoecklein S; Morenas-Rodriguez E; Bartenstein P; Levin J; Höglinger GU; Simons M; Perneczky R; Brendel M
    J Neuroinflammation; 2024 Jan; 21(1):30. PubMed ID: 38263017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
    Conti E; Grana D; Angiulli F; Karantzoulis A; Villa C; Combi R; Appollonio I; Ferrarese C; ; Tremolizzo L
    J Alzheimers Dis; 2023; 95(2):549-559. PubMed ID: 37574731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon Regulatory Factor 5 Regulates the Phagocytosis of Microglia and Alleviate Alzheimer's Pathology.
    Fan Z; Zhang X; Zhao S; Zhong S; Li Z; Yan Y; Zhang B; Chen Y
    J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38271298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
    Bai Y; Ma X
    Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing.
    Kummer MP; Vogl T; Axt D; Griep A; Vieira-Saecker A; Jessen F; Gelpi E; Roth J; Heneka MT
    J Neurosci; 2012 Dec; 32(49):17824-9. PubMed ID: 23223301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.